Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB

Al Zoubi, Sura; Chen, Jianmin; Murphy, Catherine; Martin, Lukas; Chiazza, Fausto; Collotta, Debora; Yaqoob, Muhammad M.; Collino, Massimo; Thiemermann, Christoph

doi:10.3389/fimmu.2018.02996

Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB

By Sura Al Zoubi, Jianmin Chen, Catherine Murphy, Lukas Martin, Fausto Chiazza, Debora Collotta, Muhammad M. Yaqoob, Massimo Collino and Christoph Thiemermann

Get PDF (2 MB)

Topics: DPP-4; IKK-16; linagliptin; mice; NF-κB; sepsis; septic cardiomyopathy; type 2 diabetes mellitus; Immunology and Allergy; Immunology

Publisher: 'Frontiers Media SA'

Year: 2018

DOI identifier: 10.3389/fimmu.2018.02996

OAI identifier: oai:iris.unito.it:2318/1689032

Provided by: Institutional Research Information System University of Turin

Downloaded from https://iris.unito.it/bitstream/2318/1689032/1/2018%20Frontiers%20Immunology%20Linagliptin.pdf

Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB

Suggested articles